Shares of agilon health, inc. (NYSE:AGL – Get Free Report) have earned a consensus recommendation of “Hold” from the nineteen analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $8.57.
AGL has been the subject of several recent research reports. Baird R W raised shares of agilon health to a “hold” rating in a research report on Thursday, May 30th. Truist Financial raised their price target on shares of agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a report on Friday, May 24th. Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Robert W. Baird began coverage on shares of agilon health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $6.00 price objective for the company. Finally, Evercore ISI lifted their target price on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 9th.
View Our Latest Stock Report on AGL
agilon health Stock Down 9.0 %
agilon health (NYSE:AGL – Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting the consensus estimate of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company’s revenue was up 38.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.04) earnings per share. Research analysts anticipate that agilon health will post -0.32 EPS for the current fiscal year.
Insider Activity at agilon health
In related news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 3.20% of the company’s stock.
Institutional Trading of agilon health
Several hedge funds have recently bought and sold shares of the company. J.Safra Asset Management Corp grew its position in agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after purchasing an additional 3,625 shares during the last quarter. Quest Partners LLC acquired a new position in shares of agilon health during the fourth quarter worth approximately $45,000. Neo Ivy Capital Management bought a new position in agilon health in the 4th quarter worth approximately $47,000. CWM LLC grew its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC acquired a new stake in agilon health in the 2nd quarter valued at approximately $60,000.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
- Five stocks we like better than agilon health
- Health Care Stocks Explained: Why You Might Want to Invest
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How to Invest in the Best Canadian Stocks
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Investing in Commodities: What Are They? How to Invest in Them
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.